CMS-D002 Capsule

· Shenzhen Kangzhe Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMS-D002 Capsule, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia [Phase 2]